The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: Most-read Content in September

Here is a recap of what DAIC viewers found most interesting during the month of September: 1. Unloading with Impella for ...

Home October 03, 2022
Home
Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home
News | Heart Failure
scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting

October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...

Home October 03, 2022
Home
The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice
News | Wearables
Mawi launches Mawi Heart Patch

October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring ...

Home October 03, 2022
Home
The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.
News | Congenital Heart
Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the ...

Home October 03, 2022
Home
HeartBeam (1)
News | ECG
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

September 29, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

Home September 29, 2022
Home
Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation, a common heart rhythm disorder
News | Artificial Intelligence
AI-guided Screening Uses ECG Data to Detect a Hidden Risk Factor for Stroke

September 29, 2022 — Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ ...

Home September 29, 2022
Home
Higher blood levels of collagen-derived molecule predict worse outcomes
News | Heart Failure
Penn Study Identifies New Prognostic Biomarker for Heart Failure

September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in ...

Home September 29, 2022
Home
The multi-center first-in-men study evaluates the safety and performance of the next generation of BIOTRONIK’s Resorbable Magnesium Scaffold (RMS)
News | Stents Bioresorbable
BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold

September 28, 2022 — In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...

Home September 28, 2022
Home
Yeonsik Now, UMass Amherst assistant professor who holds a joint appointment in the Elaine Marieb College of Nursing and the College of Engineering’s electrical and computer engineering department, was awarded a projected four-year, $2.3 million grant from the National Institutes of Health’s National Heart, Blood and Lung Institute. Image courtesy of UMass Amherst
News | Heart Failure
Wearing a Vest With Wireless Hardware for Five Minutes a Day May Help People With Heart Failure Stay Out of the Hospital

September 28, 2022 — A University of Massachusetts Amherst nurse engineer is leading a team of researchers who are ...

Home September 28, 2022
Home
Draper engineers are developing the Low-force Expanding/Adaptable Pediatric (LEAP) Valve—the first heart valve that can grow with the patient. Credit: Draper
News | Pediatric Cardiology
Draper Advances Growth-Adaptive Pediatric Heart Valve with Sutureless Adhesive

September 28, 2022 — Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before ...

Home September 28, 2022
Home
George Washington University Researchers have found that post-stroke language and orientation impairments predicted recurrent stroke, while attention deficit impairment was associated with increased risk of death.
News | Stroke
New Study Provides Insights into Stroke Recurrence and Death in Patients with Insulin Resistance

September 28, 2022 — George Washington University researchers have found that post-stroke language and orientation ...

Home September 28, 2022
Home
Heart disease prevention pioneer Jeremiah Stamler, MD. Photo courtesy of Legacy.com
Feature | Cardiovascular Business | By Christine Book
Spotlight on Heart Disease Prevention Pioneer, Jeremiah Stamler, MD

World Heart Day takes place each year on September 29. Founded in 2000 by the World Heart Federation, World Heart Day ...

Home September 28, 2022
Home
Martha Gulati, MD, is the new director of Preventive Cardiology in the Smidt Heart Institute. Photo by Cedars-Sinai.
News | Cardiovascular Business
Smidt Heart Institute Welcomes New Director of Preventive Cardiology

September 27, 2022 — Martha Gulati, MD, an expert in preventive cardiology and women’s heart disease, has joined the ...

Home September 27, 2022
Home
Magmaris Scaffold Performs Well in Real World Settings Even in More Complex Patient Groups
News | Stents Bioresorbable
BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

September 27, 2022 — BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...

Home September 27, 2022
Home
a late breaking abstract describing dose response data from its positive Phase 2 clinical study of istaroxime in early cardiogenic shock (SEISMiC) will be presented on October 2 at the Heart Failure Society of America Annual Scientific Meeting in Washington, DC.
News | Cardiogenic Shock
Windtree Therapeutics Announces Istaroxime Late Breaker Abstract from its Positive Phase 2 Study in Early Cardiogenic Shock (SEISMiC) to be Presented at Heart Failure Society of America

September 27, 2022 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage ...

Home September 27, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now